ETBI   $0.0018  -18.18% Market Closed

EASTGATE BIOTECH CORP
Last Events:

2022-01-01 Trend pattern changed from нисходящий клин to сужающийся канал.

2022-01-01 Signal in Stochastic changed from bearish recovery to bearish. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: signal line crossed the middle level.

2022-01-01 Signal in EMA20 changed from bearish reversal to n/a. 2021-11-29 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

2022-01-01 Trend changed from linear down to down and flat.

2021-12-08 Signal in RSI changed from bearish recovery to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2021-12-08 Trend Power changed from medium strength to strong.

2021-12-05 Trend pattern changed from Not found to нисходящий клин.

2021-12-05 Signal in Stochastic changed from bullish reversal to bearish recovery. The stochastic indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: main and signal line crossing.


Current temperature: 0.00
ST: 0, Cor:

Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell -
rsi Sell Sell -
macd - Sell -
stoch Sell Sell -
ma20 - - -
ma50 Sell - -
ma100 Sell - -
ISIN US2772531008
ceo Ms. Rosella C. Perri
Website https://www.EastGateBiotech.com
Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes. It is also developing natural products and dietary supplements, including E-drops Nano and PURALEN that are self-nanoemulsifying compositions containing natural essential oils for oral administration; Glucora, a soft gelatin capsule with Banaba extract in self-emulsifying formulation for oral administration; URBAN POWER, a soft gelatin capsule with Ursolic acid and Banaba extract in self-emulsifying formulation for oral administration; Vitamin D3 nanoemulsion, a nanoemulsion with cholecalciferol; and Cleanezze, a hand sanitizer containing oil. Eastgate Biotech Corp. has collaboration with Biotech Corp. to develop a vaccine against COVID-19. The company was formerly known as Eastgate Acquisitions Corporation and changed its name to Eastgate Biotech Corp. in December 2014. Eastgate Biotech Corp. was founded in 1999 and is based in Toronto, Canada.